Dow Today: Johnson & Johnson (JNJ) Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 69 points (+0.4%) at 17,147 as of Thursday, Sep 4, 2014, 10:36 a.m. ET. During this time, 65.4 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 297.6 million. The NYSE advances/declines ratio sits at 1,810 issues advancing vs. 1,060 declining with 198 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ), which is sporting a 24-cent gain (+0.2%) bringing the stock to $104. This single gain is lifting the Dow Jones Industrial Average by 1.82 points or roughly accounting for 2.6% of the Dow's overall gain. Volume for Johnson & Johnson currently sits at 2.3 million shares traded vs. an average daily trading volume of 6.2 million shares.

Johnson & Johnson has a market cap of $291.5 billion and is part of the health care sector and drugs industry. Shares are up 13.3% year-to-date as of Wednesday's close. The stock's dividend yield sits at 2.7%.

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

If you liked this article you might like

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'

Johnson & Johnson Stock Sinks, Goldman Downgrades to 'Sell'

The Best Companies for Women